BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen X, Chen S, Yu D. Protein kinase function of pyruvate kinase M2 and cancer. Cancer Cell Int 2020;20:523. [PMID: 33292198 DOI: 10.1186/s12935-020-01612-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Słomka A, Kornek M, Cho WC. Small Extracellular Vesicles and Their Involvement in Cancer Resistance: An Up-to-Date Review. Cells 2022;11:2913. [PMID: 36139487 DOI: 10.3390/cells11182913] [Reference Citation Analysis]
2 Fan N, Fu H, Feng X, Chen Y, Wang J, Wu Y, Bian Y, Li Y. Long non-coding RNAs play an important regulatory role in tumorigenesis and tumor progression through aerobic glycolysis. Front Mol Biosci 2022;9:941653. [DOI: 10.3389/fmolb.2022.941653] [Reference Citation Analysis]
3 Ni L, Lin B, Hu L, Zhang R, Fu F, Shen M, Yang J, Shi D. Pyruvate Kinase M2 Protects Heart from Pressure Overload-Induced Heart Failure by Phosphorylating RAC1. J Am Heart Assoc 2022;:e024854. [PMID: 35656980 DOI: 10.1161/JAHA.121.024854] [Reference Citation Analysis]
4 Das R, Ghosh Chowdhury M, Raundal S, Jadhav J, Kumar N, Patel S, Shard A. Objective assessment of adrenocortical carcinoma driver genes and their correlation with tumor pyruvate kinase M2. Gene 2022;822:146354. [PMID: 35189247 DOI: 10.1016/j.gene.2022.146354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hou D, Xiao W, Wang J, Yaseen M, Wang Z, Fei Y, Wang M, Wang L, Wang H, Shi X, Cai M, Feng H, Xu W, Li L. OGA activated glycopeptide-based nano-activator to activate PKM2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tőkés AM, Vári-kakas S, Kulka J, Törőcsik B. Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas. Front Oncol 2022;12:850401. [DOI: 10.3389/fonc.2022.850401] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ishfaq M, Bashir N, Riaz SK, Manzoor S, Khan JS, Bibi Y, Sami R, Aljahani AH, Alharthy SA, Shahid R. Expression of HK2, PKM2, and PFKM Is Associated with Metastasis and Late Disease Onset in Breast Cancer Patients. Genes 2022;13:549. [DOI: 10.3390/genes13030549] [Reference Citation Analysis]
8 Lavik AR, McColl KS, Lemos FO, Kerkhofs M, Zhong F, Harr M, Schlatzer D, Hamada K, Mikoshiba K, Crea F, Bultynck G, Bootman MD, Parys JB, Distelhorst CW. A non-canonical role for pyruvate kinase M2 as a functional modulator of Ca2+ signalling through IP3 receptors. Biochim Biophys Acta Mol Cell Res 2022;1869:119206. [PMID: 35026348 DOI: 10.1016/j.bbamcr.2021.119206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Arora S, Joshi G, Chaturvedi A, Heuser M, Patil S, Kumar R. A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2. J Med Chem 2021. [PMID: 34726055 DOI: 10.1021/acs.jmedchem.1c00981] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ren X, Huang X, Wu Q, Tan L, Fu C, Chen Y, Meng X. Nanoscale metal organic frameworks inhibition of pyruvate kinase of M2. Chinese Chemical Letters 2021;32:3087-9. [DOI: 10.1016/j.cclet.2021.03.081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Maleki M, Golchin A, Javadi S, Khelghati N, Morovat P, Asemi Z, Alemi F, Vaghari-Tabari M, Yousefi B, Majidinia M. Role of exosomal miRNA in chemotherapy resistance of Colorectal cancer: A systematic review. Chem Biol Drug Des 2021. [PMID: 34480511 DOI: 10.1111/cbdd.13947] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Sun T, Liu Z, Bi F, Yang Q. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2. Mol Oncol 2021. [PMID: 34382324 DOI: 10.1002/1878-0261.13076] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
13 Li H, Yan M, Wu X, Wang Y, Huang L. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis. Medicine (Baltimore) 2021;100:e25545. [PMID: 33950928 DOI: 10.1097/MD.0000000000025545] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Li T, Xian HC, Dai L, Tang YL, Liang XH. Tip of the Iceberg: Roles of CircRNAs in Cancer Glycolysis. Onco Targets Ther 2021;14:2379-95. [PMID: 33854335 DOI: 10.2147/OTT.S297140] [Cited by in F6Publishing: 4] [Reference Citation Analysis]